Cryoport Inc (CYRX) 13F Filing Data & Analysis (Q2 2026)

CYRX ranks #3169 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

CYRX is a disclosed holding of Israel Englander (Millennium Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

187 institutions disclose a position in CYRX, but none treat it as a major bet — even Meros Investment Management, LP, its most concentrated holder, allocates just 3.7% of its own portfolio to it.

Susquehanna International Group, LLP has added to its CYRX position for two straight quarters, increasing it by $17.6M to reach $24.1M today.

Morgan Stanley has trimmed its CYRX position for two straight quarters, cutting it by $8.3M while still holding $35.7M.

CYRX is up 1.5% today, and institutions have been net buyers of $16.3M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

CYRX reported a net loss of $37.4M over the trailing twelve months.

• Not yet profitable — net loss of $37.4M over the trailing twelve months
• Revenue grew 12.1% year over year
• Net income declined year over year, from $79.0M to -$37.4M
• Operating cash flow was negative, using $8.6M in cash
• Current ratio of 2.17x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.52x equity — within a conventional range